By David Wallace 15 Apr 2021
Details of how the FDA plans to conduct remote evaluations of manufacturing facilities during the COVID-19 pandemic have been set...
The US Biosimilars Perspectives article pack – your key to critical insights.
Your free pack includes the articles:
By Dean Rudge 15 Apr 2021
Hikma has won more time to respond to Amarin’s certiorari petition to the US Supreme Court over a Federal Circuit...
15 Apr 2021
Biosimilars industry stakeholders have suggested ways to enhance communication and improve the US regulatory pathway for biosimilars, as they weighed...
Whether you’re a small biotech start-up, research firm, generic manufacturer or a global pharmaceutical giant, you need focused, independent insight and opinion on market developments.
Our team is always happy to hear from you. Please call us at:
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now: